ESC Premium Access

Spironolactone in patients with permanent atrial fibrillation, possible heart failure protective potential.

Topic: Mechanisms for Heart Failure and Cardiac Complications

Congress Presentation

About the speaker

Professor Rafal Dabrowski

National Institute of Cardiology, Warsaw (Poland)
0 follower

9 more presentations in this session

Circulating biomarkers of myocardial fibrosis and cellular apoptosis in patients with atrial fibrillation and heart failure with preserved ejection fraction

Speaker: Associate Professor M. Dzeshka (Grodno, BY)

Thumbnail

Left ventricular stiffness assessed by diastolic wall strain predicts infrequent atrial fibrillation

Speaker: Doctor H. Kishima (Nishinomiya, JP)

Thumbnail

Outcomes of heart failure with reduced ejection fraction (HFrEF) status post implantable cardioverter-defibrillator (ICD) presenting with HFrEF exacerbation with verses without atrial fibrillation(AF)

Speaker: Doctor H. Arshad (Newark, US)

Thumbnail

The impact of elective cardioversion for atrial fibrillation in heart failure patients

Speaker: Doctor J. Graby (Bath, GB)

Thumbnail

MOODS: a novel risk score to identify patients with atrial fibrillation and sleep apnoea

Speaker: Doctor K. Kadhim (Adelaide, AU)

Thumbnail

Access the full session

Poster Session 4 - Epidemiology of atrial fibrillation, miscellaneous

Speakers: Professor R. Dabrowski, Associate Professor M. Dzeshka, Doctor H. Kishima, Doctor H. Arshad, Doctor J. Graby...
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations